Researchers feel that combining navitoclax with ruxolitinib may help those with myelofibrosis. Within this demo 50 percent the individuals have navitoclax and ruxolitinib. The other half have ruxolitinib plus a dummy drug (placebo ). Skip to primary written content Thanks for visiting nature.com. You happen to be using a browser https://gallagherx111kwk5.snack-blog.com/profile